Financials

  • Market Capitalization 189.6 M
  • Employee 108
  • Founded 2015
  • CEO N/A
  • Website www.nkartatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00JXHS9G7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.31
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3646
KRRO
Korro Bio, Inc. - Common Stock
13.27 USD-1.70%-7.14%+13.91%-65.89%191.39 M USD
3648
VYGR
Voyager Therapeutics, Inc. - Common Stock
3.16 USD-2.47%-15.73%-13.66%-32.04%190.93 M USD
3653
QSI
Quantum-Si Incorporated - Class A Common Stock
0.87 USD0.00%-2.25%-12.12%-50.29%189.45 M USD
3658
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
3.81 USD-0.78%-7.07%-6.16%+26.58%188.41 M USD

Notizie